A Rare Case of Dengue Myocarditis: Challenges in Diagnosis and Management
DOI:
https://doi.org/10.53685/jshmdc.v5i1.217Keywords:
Dengue fever, Myocarditis, Diagnosis, ManagementAbstract
Dengue fever is a viral infection prevalent worldwide in tropical and subtropical regions and affects millions of people annually. It is associated with several complications, including rare yet significant cardiac complications, such as myocarditis. Myocarditis caused by dengue fever is challenging to diagnose and can be initially mistaken for acute coronary syndrome. This case report describes the diagnostic and management difficulties encountered by examining a young male patient who developed myocarditis as a complication of severe dengue fever. A 30-year-old male, a known smoker, presented to the emergency department with chest pain, diaphoresis, and hypotension. ECG indicated inferior wall ST-T changes. A physical examination revealed no abnormalities. The patient had a five-day history of fever and myalgia. The patient was initially diagnosed with acute coronary syndrome and cardiogenic shock. Primary coronary angiography revealed no abnormal findings. Echocardiography revealed a decreased LV ejection fraction of 40% and global wall hypokinesia with normal chamber dimensions, necessitating further investigation of the etiology. Subsequently, he was diagnosed with dengue virus-induced myocarditis based on laboratory investigations. This case underscores the rarity of dengue-associated myocarditis and emphasizes the pivotal role of maintaining a high clinical suspicion index for early diagnosis and management. Additionally, it emphasizes the significance of continuous case reporting to enhance our understanding and shape the evidence-based practices to address this uncommon complication.
References
Dengue guidelines for diagnosis, treatment, prevention and control treatment, prevention and control treatment, prevention and control. Accessed August 24, 2023. https://www.who.int/publications/I/ item/9789241547871
Gulati S, Maheshwari A. Atypical manifestations of dengue. Trop Med Int Health. 2007;12(9):1087-1095. doi:10.1111/j.1365-3156.2007.01891.x
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013; 496(7446): 504-507. doi: 10.1038/nature12060
Ahmad MH, Ibrahim MI, Mohamed Z, Ismail N, Abdullah MA, Shueb RH, et al. The sensitivity, specificity, and accuracy of warning signs in predicting severe dengue, the severe dengue prevalence, and its associated factors. Int J Environ Res Public Health. 2018; 15(9): 2018. doi:10.3390/ijerph15092018
Zhang FC, Zhao H, Li LH, Jiang T, Hong WX, Wang J, et al. Severe dengue outbreak in Yunnan, China, 2013. Int J Infect Dis. 2014; 27: 4-6. doi: 10.1016/j.ijid.2014.03.1392.
Malik J, Iltaf Satti D. 78 Cardiovascular manifestations of dengue, Heart 2022; 108: A58. doi:10.1136/HEARTJNL-2022-BCS.78
Kaagaard MD, Wegener A, Gomes LC, Holm AE, Lima KO, Matos LO, et al. Potential role of transthoracic echocardiography for screening LV systolic dysfunction in patients with a history of dengue infection. A cross-sectional and cohort study and review of the literature. PLoS One. 2022; 17(11): e0276725. doi: 10.1371/journal.pone.0276725.
Baqi A, Ur Rehman F, Memon PS, Omair SF. Prevalence and Outcomes of Myocarditis in Dengue-Infected Patients Admitted at a Tertiary Care Hospital of Low-Middle Income Country. Glob Heart. 2022; 17(1). doi:10.5334/GH.1129.
Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. The current state of knowledge on etiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33): 2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210
Ullah A, Khan S, Ahmad A, Irfan M, Majeed I. Perimyocarditis: An Unusual Manifestation of Dengue Virus Infection. Cureus. 2023;15(4):e37093. doi: 10.7759/cureus.37093.11.
Adams CD, Syro D, Llano JF, Betancur JF. Myocarditis: an uncommon manifestation of dengue fever infection. BMJ Case Rep. 2021; 14(2): 241569. doi:10.1136/BCR-2021-241569
Salgado DM, Eltit JM, Mansfield K, Panqueba C, Castro D, Vega MR, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J. 2010; 29(3): 238-242.doi:10.1097/INF.0b013e 3181bc3c5b
Lima Mda R, Nogueira RM, Schatzmayr HG, de Filippis AM, Limonta D, dos Santos FB. A new approach to dengue fatal cases diagnosis: NS1 antigen capture in tissues. PLoS Negl Trop Dis. 2011; 5(5): e1147. doi:10.1371/journal. and.00011 47.14.
Cristodulo R, Luoma-Overstreet G, Leite F, Vaca M, Navia M, Durán G, et al. Dengue Myocarditis: A Case Report and Major Review. Glob Heart. 2023; 18(1):41. doi: 10.5334/gh.1254.
Satarasinghe RL, Arultnithy K, Amerasena NL, Bulugahapitiya U, Sahayam DV. Asymptomatic myocardial involvement in acute dengue virus infection in a cohort of adult Sri Lankans admitted to a tertiary referral centre. Br J Cardiol. 2007; 14(3):171-73.
Jadav N, Vaghela N, Verma N, Davis D, Sonani AA, Patoliya P. Unmasking the hidden threat of cardiac involvement in dengue fever: a critical longitudinal study. Cureus. 2023;15(9): e45961. doi: 10.7759/cureus.45961.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hafiz Muhammad Mubeen Nawaz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
Non Commercial — You may not use the material for commercial purposes.
-
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.